Skip to main content
Mark Metzl, MD, Cardiology, Evanston, IL, Westlake Hospital

MarkDavidMetzlMD

Cardiology Evanston, IL

Adult Congenital Heart Disease, Cardiac Electrophysiology

Section Chief, Cardiac Electrophysiology

Dr. Metzl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Metzl's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Clinical Cardiac Electrophysiology, 2010 - 2011
  • Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)
    Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2007 - 2010
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2010 - 2026
  • NY State Medical License
    NY State Medical License 2006 - 2011
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Keeping the Beat
    Keeping the BeatSeptember 10th, 2019
  • Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-Related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures
    Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-Related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation ProceduresSeptember 15th, 2023
  • Clinical and Operational Benefits of an Electronic Medical Record Alert for Patients with Cardiac Implantable Electronic Device Infection
    Clinical and Operational Benefits of an Electronic Medical Record Alert for Patients with Cardiac Implantable Electronic Device InfectionDecember 1st, 2023

Professional Memberships

Hospital Affiliations